Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary NeuroMetrix Reports Strong Quell Demand in Q4 2016
Invoiced Value of Quell Shipments Up 19% Over Q3 2016 WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (the "Company") (Nasdaq: NURO, NUROW) reported Q4 2016 demand highlights for its Quell ®  Wearable Pain Relief Technology™. During Q4 2016 the invoiced value of Quell shipments totaled
View HTML
Toggle Summary NeuroMetrix, Inc. Announces Date for 2016 Full Year and Fourth Quarter Financial Results Conference Call
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (NASDAQ: NURO, NUROW) announced today that it plans to issue its 2016 full year and fourth quarter financial results before the opening of the market on January 26, 2017 . The Company will host a conference call at 8:00 a.m., Eastern Time on
View HTML
Toggle Summary NeuroMetrix Reports Q4 and Full Year 2016 Financial Results
2016 revenue $12.0M up 65% year-on-year; Q4 revenue $3.7M up 36% Quell device shipments of 14.3K and electrode reorders of 20K represent new quarterly highs WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO, NUROW), today reported financial and business highlights for the quarter
View HTML
Toggle Summary NeuroMetrix Announces Availability of Quell Wearable Pain Relief Technology at Best Buy
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that Quell ® will be available in over 450 Best Buy ® stores nationwide beginning in mid-February and is now available for purchase on BestBuy.com . "More and more consumers are proactively looking for technology to
View HTML
Toggle Summary NeuroMetrix Gaining Increased Media Coverage of Quell Wearable Pain Relief Technology in 2017
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) reported increased media attention in 2017 on the company's Quell ® Wearable Pain Relief Technology™. An Inside Look at the Latest Health Tech - The Dr. Oz Show 3 Amazing New Gadgets to Relieve Aches & Pains - Fox News Could this
View HTML
Toggle Summary NeuroMetrix Brings Quell Wearable for Pain Relief to American Academy of Pain Medicine 33rd Annual Meeting
Waltham -based company to exhibit its wearable device for widespread pain relief ORLANDO, Fla. --(BUSINESS WIRE)-- Coming together with thousands of leading clinicians who treat patients with chronic pain, NeuroMetrix, Inc. (Nasdaq: NURO) will exhibit Quell ® , its FDA -cleared, 100% drug-free
View HTML
Toggle Summary NeuroMetrix, Inc. Announces Date for 2017 First Quarter Financial Results Conference Call
WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix , Inc. (Nasdaq: NURO) announced today that it plans to issue its 2017 first quarter financial results before the opening of the market on Thursday, April 20, 2017. The Company will host a conference call at 8:00 a.m., Eastern Time on April 20, 2017 to
View HTML
Toggle Summary NeuroMetrix Named a 50+ Innovation Leader
Inaugural initiative of AARP and MedCity News showcases companies and people delivering cutting-edge healthcare solutions for the 50+ market MOUNTAIN VIEW, Calif. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) announced today that it was selected as one of the healthcare industry's 50+
View HTML
Toggle Summary NeuroMetrix Announces Availability of Quell Wearable Pain Relief Technology at Bed Bath & Beyond
Waltham -based company expands availability into brick-and-mortar locations of leading domestic and home merchandise retailer WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO) today announced the availability of its flagship product, Quell ® , at select number of Bed Bath & Beyond
View HTML
Toggle Summary NeuroMetrix Reports Q1 2017 Financial Results
Revenue of $4.3M is up 89% year-over-year Quell device shipments of 18.7K and electrode reorders of 25.4K represent new quarterly highs Quell retail availability expands to nearly 3,000 stores WALTHAM, Mass. --(BUSINESS WIRE)-- NeuroMetrix, Inc. (Nasdaq: NURO), today reported financial and business
View HTML